CNBC February 8, 2024
Key Points
– Senators are grilling the CEOs of Johnson & Johnson, Merck and Bristol Myers Squibb on high U.S. drug prices at a hearing.
– J&J CEO Joaquin Duato, Merck CEO Robert Davis and Bristol Myers Squibb CEO Chris Boerner will testify about why their companies charge substantially higher prices for medicine in the U.S. than in other countries.
– The push to cut drug prices is one of those rare hot-button issues that unites the two major political parties.
Senators are questioning the CEOs of Johnson & Johnson, Merck and Bristol Myers Squibb on U.S. drug prices at a hearing Thursday, as lawmakers on both sides of the aisle work to rein in high health-care costs for Americans....
Today's Sponsors
Today's Sponsor